New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 1, 2014
15:20 EDTFURX, ACTFuriex stockholders approve acquisition by Actavis
The stockholders of Furiex Pharmaceuticals (FURX) voted at a special meeting to adopt the previously announced agreement and plan of merger, dated as of April 27, providing for the merger of Furiex with an entity now controlled by Forest Laboratories, a subsidiary of Actavis (ACT). Furiex also announced that it has received notice of clearance of the proposed merger from the Ukrainian Antimonopoly Committee. Actavis completed its acquisition of Forest Laboratories on July 1.
News For FURX;ACT From The Last 14 Days
Check below for free stories on FURX;ACT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 1, 2014
17:02 EDTACTActavis files to sell 843,085 ordinary shares
The offering is related to shares that may be issued upon the exercise of stock options granted under certain equity plans of Forest Laboratories to former employees or former directors of Forest.
July 23, 2014
10:02 EDTACTOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:10 EDTACTDeutsche Bank hosts an analyst Specialty Pharma/Industry conference call
Subscribe for More Information
July 22, 2014
16:09 EDTACTActavis initiated with a Buy at Deutsche Bank
Subscribe for More Information
July 21, 2014
16:36 EDTACTActavis and Medicines360 announce FDA acceptance of Levosert NDA
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use